Vimal Mehta, CEO and President: BioXcel Therapeutics BTAIQ Sell · Filed 24/09/17

Trade details

Type: Insider sale
Amount: $793.5
Shares · price: 1,150 sh · $0.69 a share
Held after: 51,666 sh
Stock: BioXcel Therapeutics BTAIQ
Person: Vimal MehtaCEO and President
Trade date: 24/09/16
Filed: 24/09/17
Days to filing: 1 days

Sold 2.2% of holdings

Share of holding sold: 2.2%

BioXcel Therapeutics trades, last 26 weeks

What else happened in BioXcel Therapeutics around then

Filed or reported within 30 days of the trade day · 24/08/17~24/10/16

Vimal Mehta's recent trades

Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$21.2K
19,419 sh
$21.2K
Filed 05/22
Traded 05/20
Vimal MehtaCEO and President
Planned sale10b5-1 planBioXcel Therapeutics
Planned sale10b5-1 plan
BioXcel Therapeutics
BTAIQ
$21.1K
19,419 sh
$21.1K
Filed 05/20
Traded 05/20
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$354
983 sh
$354
Filed 24/12/17
Traded 24/12/16
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$768
2,134 sh
$768
Filed 24/12/17
Traded 24/12/16
Vimal MehtaCEO and President
Sell10b5-1 planBioXcel Therapeutics
Sell10b5-1 plan
BioXcel Therapeutics
BTAIQ
$574
832 sh
$574
Filed 24/09/17
Traded 24/09/16

Vimal Mehta, CEO — sold $794 of BioXcel Therapeutics BTAIQ · 2.2% of holdings · 10b5-1 plan | Whalegun